Yesterday, Cord Blood America revealed on the National Business Radio Show ‘Your Monies Worth’, that they are nearing completion of eliminating debt. The CEO, Matthew Schissler, commented that the debt has helped the company grow rapidly, but he has concerns that the stock price is effected by the debt.
Clearing Debt and Growing Positively were two main priorities for Cord Blood America this year, and the CEO believes that the company has been executing both plans well. From 2005 to 2006, revenues grew 71%.
Mr. Schissler summed his company’s growth, “The Company, going forward, is focused on strategic accretive acquisitions, intelligent organic growth and becoming the nation’s first sustainable cash flow positive stem cell storage company.”
Let us hear your thoughts below: